Targeting cardiovascular and metabolic risk modification in end stage renal disease (ESRD): a randomized controlled clinical trial on niacin’s effects on lipoprotein(a) and biochemical markers in hemodialysis patients
Authors
Azza A. Ali (ORCID: https://orcid.org/0000-0002-3700-7199)
Zeinab Al Kasaby Zalat
Ammena Y. Binsaleh (ORCID: https://orcid.org/0009-0007-7174-3839)
Targeting cardiovascular and metabolic risk modification in end stage renal disease (ESRD): a randomized controlled clinical trial on niacin’s effects on lipoprotein(a) and biochemical markers in hemodialysis patients
Azza A. Ali, Zeinab Al Kasaby Zalat, Ammena Y. Binsaleh, Ashraf Galal et al.
Citations
1 citations
Journal
Frontiers in Medicine
Topics
Diet and metabolism studies
Field-Weighted Citation Impact (FWCI)
1.16
article
Targeting cardiovascular and metabolic risk modification in end stage renal disease (ESRD): a randomized controlled clinical trial on niacin’s effects on lipoprotein(a) and biochemical markers in hemodialysis patients
Azza A. Ali, Zeinab Al Kasaby Zalat, Ammena Y. Binsaleh, Ashraf Galal, Nawal Alsubaie, Ghadir Mohamed Elsawy, Ahmed Hassan Elthakaby, M. Salah, Amani S. Alrossies
article en
1 citations
Abstract
No abstract available for this paper.
Publication Tag
Frontiers in MedicineVol. 12
Institutions
Princess Nourah bint Abdulrahman University (SA), Al-Azhar University (EG)